Health / Medical Topics

    Interleukin-1 Receptor-Associated Kinase 4

    Widely expressed (strongest in kidney and liver) by human IRAK4 Gene, 460-aa Interleukin-1 Receptor-Associated Kinase 4 contains (like IRAK1, IRAK2, IRAKM, and Pelle) an N-terminal death domain and a central kinase domain. Similar to Pelle, IRAK4 has a short C-terminal domain. Like all IL1R-associated kinases, IRAK4 mediates Toll/IL1R family receptor signal transduction. Like IRAK1 and Pelle, IRAK4 has auto- and cross-phosphorylation activity. IRAK4 phosphorylates and activates IRAK1. It also interacts with MYD88 and TRAF6 and activates MAPK and NF kappa-B pathways. IRAK4 may act as an IRAK1 kinase, triggering phosphorylation cascades. (NCI Thesaurus)




    YOU MAY ALSO LIKE

    Expressed in peripheral leukocytes and monocytes by human IRAK3 Gene, 596-aa Interleukin-1 Receptor-Associated Kinase 3 contains an N-terminal death domain and central…
    Interleukin-1 receptor-associated kinase 1 (712 aa, ~77 kDa) is encoded by the human IRAK1 gene. This protein plays a role in protein…
    Encoded by human IL1R2 Gene (IL1R Family), 398-aa 45-kDa (precursor) Interleukin 1 Receptor Beta Type II is a type I membrane protein…
    Interleukin-1 receptor antagonist protein (177 aa, ~20 kDa) is encoded by the human IL1RN gene. This protein is involved in the inhibition…
    Encoded by human IL1R1 Gene (IL1R Family), 569-aa 65-kDa (precursor) Interleukin-1 Receptor Alpha Type I is a type I membrane protein cytokine…
    Interleukin-1 beta (269 aa, ~31 kDa) is encoded by the human IL1B gene. This protein is involved in the macrophage-dependent inflammatory…

    © 1991-2023 The Titi Tudorancea Bulletin | Titi Tudorancea® is a Registered Trademark | Terms of use and privacy policy
    Contact